CN Stock MarketDetailed Quotes

Brightgene Bio-Medical Technology Co.,Ltd. (688166)

Watchlist
  • 53.06
  • +1.88+3.67%
Market Closed Apr 10 15:00 CST
22.45BMarket Cap411.32P/E (TTM)

Brightgene Bio-Medical Technology Co.,Ltd. (688166) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
原料药-其他类408.15M33.36%
原料药-抗真菌类320.09M26.16%
制剂类176.19M14.40%
技术权益及服务收入110.53M9.03%
原料药-免疫抑制类104.84M8.57%
原料药-抗病毒类69.7M5.70%
Other business34.14M2.79%
Total special adjustments--
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.19B97.21%
Other business34.14M2.79%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic sales669.79M54.74%
Export sales519.71M42.47%
Other business34.14M2.79%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More